Chatbot Intervention for Anxiety and Depressive Symptoms in Young Adults
Effectiveness of a Therapy Chatbot on Anxiety and Depressive Symptoms in Subclinical Young Adults: A Randomized Controlled Trial
1 other identifier
interventional
81
1 country
1
Brief Summary
This clinical trial compares the effects of using an artificial intelligence based therapy chatbot and a self-help book to lower anxiety and depressive symptoms. The therapy chatbot (named Fido) is an application delivering support for mental health via a conversation-like interface in a highly inflected language (Polish). The team will recruit young people (aged 18-35) who currently struggle with anxiety and/or depression. The participants will use the chatbot or self-help materials for two weeks. Then, the researchers will check if using the chatbot or the book improved several aspects of mental health and the quality of life. Moreover, they will compare the groups for any differences in outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable anxiety
Started May 2022
Shorter than P25 for not_applicable anxiety
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 3, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 2, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 2, 2022
CompletedFirst Submitted
Initial submission to the registry
February 10, 2023
CompletedFirst Posted
Study publicly available on registry
March 10, 2023
CompletedMarch 10, 2023
February 1, 2023
3 months
February 10, 2023
February 27, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
CESD-R Score Change
The total sum score of the Polish version of the Center for Epidemiologic Studies Depression Scale Revised.
Time point 1: Just prior to the intervention. Time point 2: Immediately after two weeks of the intervention. Time point 3: One month after the previous measurement (time point 2).
PHQ-9 Score Change
The total sum score of the Polish version of the Patient Health Questionnaire-9.
Time point 1: Just prior to the intervention. Time point 2: Immediately after two weeks of the intervention. Time point 3: One month after the previous measurement (time point 2).
PSWQ Score Change
The total sum score of the Polish version of the Penn State Worry Questionnaire.
Time point 1: Just prior to the intervention. Time point 2: Immediately after two weeks of the intervention. Time point 3: One month after the previous measurement (time point 2).
SWLS Score Change
The total sum score of the Polish version of the Satisfaction With Life Scale.
Time point 1: Just prior to the intervention. Time point 2: Immediately after two weeks of the intervention. Time point 3: One month after the previous measurement (time point 2).
PANAS Score Change
The total sum scores of the Polish version of the Positive and Negative Affect Scale in two subscales (Positive and Negative Affect, separately).
Time point 1: Just prior to the intervention. Time point 2: Immediately after two weeks of the intervention. Time point 3: One month after the previous measurement (time point 2).
STAI Score Change
The total sum score of the Polish version of the State-Trait Anxiety Inventory.
Time point 1: Just prior to the intervention. Time point 2: Immediately after two weeks of the intervention. Time point 3: One month after the previous measurement (time point 2).
R-UCLA Score Change
The total sum score of the Polish version of the Revised UCLA Loneliness Scale.
Time point 1: Just prior to the intervention. Time point 2: Immediately after two weeks of the intervention. Time point 3: One month after the previous measurement (time point 2).
Other Outcomes (5)
ACC Score
Time point 2: Immediately after two weeks of the intervention.
HCI Scores
Time point 2: Immediately after two weeks of the intervention.
LP Score
Time point 2: Immediately after two weeks of the intervention.
- +2 more other outcomes
Study Arms (2)
Chatbot
EXPERIMENTALIntervention using a pre-release version of Fido (https://fido.aid.pl), Polish AI-based therapy chatbot.
Control (book)
ACTIVE COMPARATORIntervention using self-help materials - chapters from a popular book on cognitive therapy, including worksheets.
Interventions
Participants in this condition were asked to use Fido, a Polish therapy chatbot, for two weeks. No minimal requirements of usage time were enforced, but participants had to fill in five engagement check surveys during the intervention period. Each survey had to be completed in less than 24 hours.
Participants in this condition were told to read selected chapters from a self-help book during the two-week intervention period. No minimal requirements of usage time were enforced, but participants had to fill in five engagement check surveys during the intervention period. Each survey had to be completed in less than 24 hours.
Eligibility Criteria
You may qualify if:
- declaring at least mild depressive or anxiety symptoms by achieving a total score of at least 16 points on Center for Epidemiologic Studies Depression Scale Revised or at least 50 points on Penn State Worry Questionnaire
- being able to visit the study site in Poznań (Poland) to complete all measurements
You may not qualify if:
- undergoing psychotherapy, coaching or psychopharmacological treatment
- being diagnosed with a neurological disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Laboratory of Affective Neuroscience in Poznań, SWPS University of Social Sciences and Humanities
Poznan, Greater Poland Voivodeship, 61-719, Poland
Related Publications (12)
Tariman JD, Berry DL, Halpenny B, Wolpin S, Schepp K. Validation and testing of the Acceptability E-scale for web-based patient-reported outcomes in cancer care. Appl Nurs Res. 2011 Feb;24(1):53-8. doi: 10.1016/j.apnr.2009.04.003. Epub 2009 Sep 18.
PMID: 20974066BACKGROUNDRussell D, Peplau LA, Cutrona CE. The revised UCLA Loneliness Scale: concurrent and discriminant validity evidence. J Pers Soc Psychol. 1980 Sep;39(3):472-80. doi: 10.1037//0022-3514.39.3.472.
PMID: 7431205BACKGROUNDMunder T, Wilmers F, Leonhart R, Linster HW, Barth J. Working Alliance Inventory-Short Revised (WAI-SR): psychometric properties in outpatients and inpatients. Clin Psychol Psychother. 2010 May-Jun;17(3):231-9. doi: 10.1002/cpp.658.
PMID: 20013760BACKGROUNDMoshe I, Terhorst Y, Philippi P, Domhardt M, Cuijpers P, Cristea I, Pulkki-Raback L, Baumeister H, Sander LB. Digital interventions for the treatment of depression: A meta-analytic review. Psychol Bull. 2021 Aug;147(8):749-786. doi: 10.1037/bul0000334.
PMID: 34898233BACKGROUNDKroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13. doi: 10.1046/j.1525-1497.2001.016009606.x.
PMID: 11556941BACKGROUNDKoziara K. Assessment of depressiveness in population. Psychometric evaluation of the Polish version of the CESD-R. Psychiatr Pol. 2016 Dec 23;50(6):1109-1117. doi: 10.12740/PP/61614. English, Polish.
PMID: 28211550BACKGROUNDFitzpatrick KK, Darcy A, Vierhile M. Delivering Cognitive Behavior Therapy to Young Adults With Symptoms of Depression and Anxiety Using a Fully Automated Conversational Agent (Woebot): A Randomized Controlled Trial. JMIR Ment Health. 2017 Jun 6;4(2):e19. doi: 10.2196/mental.7785.
PMID: 28588005BACKGROUNDCrawford JR, Henry JD. The positive and negative affect schedule (PANAS): construct validity, measurement properties and normative data in a large non-clinical sample. Br J Clin Psychol. 2004 Sep;43(Pt 3):245-65. doi: 10.1348/0144665031752934.
PMID: 15333231BACKGROUNDMeyer TJ, Miller ML, Metzger RL, Borkovec TD. Development and validation of the Penn State Worry Questionnaire. Behav Res Ther. 1990;28(6):487-95. doi: 10.1016/0005-7967(90)90135-6.
PMID: 2076086BACKGROUNDKusier AO, Folker AP. The Satisfaction with Life Scale: Philosophical Foundation and Practical Limitations. Health Care Anal. 2021 Mar;29(1):21-38. doi: 10.1007/s10728-020-00420-y. Epub 2021 Jan 2.
PMID: 33386535BACKGROUNDJulian LJ. Measures of anxiety: State-Trait Anxiety Inventory (STAI), Beck Anxiety Inventory (BAI), and Hospital Anxiety and Depression Scale-Anxiety (HADS-A). Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11(0 11):S467-72. doi: 10.1002/acr.20561. No abstract available.
PMID: 22588767BACKGROUNDKarkosz S, Szymanski R, Sanna K, Michalowski J. Effectiveness of a Web-based and Mobile Therapy Chatbot on Anxiety and Depressive Symptoms in Subclinical Young Adults: Randomized Controlled Trial. JMIR Form Res. 2024 Mar 20;8:e47960. doi: 10.2196/47960.
PMID: 38506892DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jarosław Michałowski, PhD
SWPS University of Social Sciences and Humanities, Warsaw, Poland
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 10, 2023
First Posted
March 10, 2023
Study Start
May 3, 2022
Primary Completion
August 2, 2022
Study Completion
August 2, 2022
Last Updated
March 10, 2023
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- ICF, ANALYTIC CODE
- Time Frame
- IPD and supporting documents will be available as soon as research results are published.
- Access Criteria
- IPD and supporting documents will be publicly available.
Anonymized data from all enrolled participants will be publicly available in the project's OSF repository.